NCT05916391View on ClinicalTrials.gov

Gene Therapy for Diabetic Macular Edema

PHASE1RecruitingINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2028

Conditions
Diabetic Macular Edema
Interventions
GENETIC

FT-003

Administration via intraocular injection

Trial Locations (1)

300392

RECRUITING

Tianjin Medical University Eye Hospital, Tianjin

Sponsors
All Listed Sponsors
collaborator

Tianjin Medical University Eye Hospital

OTHER

collaborator

Peking Union Medical College Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

lead

Frontera Therapeutics

INDUSTRY

NCT05916391 - Gene Therapy for Diabetic Macular Edema | Biotech Hunter | Biotech Hunter